A drug that could extend women’s fertility by five years – and help them live longer in better health – is safe for a young, healthy population, according to early results of a study.
The research into repurposing the immunosuppressant rapamycin has been hailed a “paradigm shift” in how menopause is studied.
The Validating Benefits of Rapamycin for Reproductive Aging Treatment (Vibrant) study is designed to measure whether the drug can slow ovaries ageing, thereby delaying menopause, extending fertility and reducing the risk of age-related diseases.
The study, which will eventually include more than 1,000 women, now has 34 participants aged up to 35, with more women joining every day.
Women deserve the same fertility window as men. I don’t want to receive more baby questions any more than anyone else.
you’re lecturing nature?
That’s a straw-man as I’m talking about the lack of investment into women’s health
oh. what have they been doing to men to extend their fertility windows?
and don’t go lecturing people about straw men if you didn’t bother explaining yourself.